Ana Paula de Azambuja,Bárbara do Nascimento,Samuel Ricardo Comar et al.
Ana Paula de Azambuja et al.
Rosai-Dorfman disease with spontaneous resolution: case report of a child [0.03%]
儿童朗斯代尔-多夫曼病的自发消退1例报告
Felipe Barbosa Lima,Pedro Samuel de Valões Barcelos,Ana Paula Nunes Constâncio et al.
Felipe Barbosa Lima et al.
Rosai-Dorfman disease is a self-limiting condition caused by histiocyte proliferation within the sinusoids of lymph nodes and in extranodal tissue. It is a rare disease, particularly in children, that progresses with extensive lymphadenopat...
Priscilla Tosqui,Marcio Francisco Colombo
Priscilla Tosqui
The globin family has long been defined by myoglobin and hemoglobin, proteins with the functions of oxygen storage and transportation, respectively. Recently, two new members of this family were discovered: neuroglobin present in neurons an...
Monitoring imatinib plasma concentrations in chronic myeloid leukemia [0.03%]
检测慢性粒细胞白血病患者中伊马替尼的血药浓度
Darlize Hübner Martins,Sandrine Comparsi Wagner,Tamyris Vianna Dos Santos et al.
Darlize Hübner Martins et al.
Imatinib has proved to be effective in the treatment of chronic myeloid leukemia, but plasma levels above 1,000 ng/mL must be achieved to optimize activity. Therapeutic drug monitoring of imatinib is useful for patients that do not present ...
Electrical properties of the red blood cell membrane and immunohematological investigation [0.03%]
红细胞膜的电学性质及免疫血液学研究
Heloise Pöckel Fernandes,Carlos Lenz Cesar,Maria de Lourdes Barjas-Castro
Heloise Pöckel Fernandes
Hemagglutination is widely used in transfusion medicine and depends on several factors including antigens, antibodies, electrical properties of red blood cells and the environment of the reaction. Intermolecular forces are involved in agglu...
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms [0.03%]
分子诊断BCR/ABL阴性慢性骨髓增殖性肿瘤的方法
Michelle Maccarini Barcelos,Maria Cláudia Santos-Silva
Michelle Maccarini Barcelos
Chronic myeloproliferative neoplasms arise from clonal proliferation of hematopoietic stem cells. According to the World Health Organization myeloproliferative neoplasms are classified as: chronic myelogenous leukemia, polycythemia vera, es...
Quality of assistance provided to children with sickle cell disease by primary healthcare services [0.03%]
基层医疗服务机构提供的 sickle细胞贫血病儿童救助情况分析
Ludmila Mourão Xavier Gomes,Tatiana Carvalho Reis,Magda Mendes Vieira et al.
Ludmila Mourão Xavier Gomes et al.
Objective: To evaluate the quality of healthcare provided to sickle cell disease children by primary healthcare services in a region of high prevalence. M...
Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients [0.03%]
肿瘤血液病患者穿孔素基因-398C/T多态性分析
Fernanda Bernadelli Garcia,Rafaella Kizzy Inácio Dos Reis,Lucas Emanuel Pinheiro da Silva et al.
Fernanda Bernadelli Garcia et al.
Background: Recently, single nucleotide polymorphisms (SNPs) were identified in the promoter region of the perforin gene (PRF1) and it was found that the -398T mutant allele is correlated with lower amounts of protein in ...
Quantification of CD8(+)CD38(+) T lymphocytes by flow cytometry does not represent a good biomarker to monitor the reactivation of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [0.03%]
流式细胞仪定量CD8(+)CD38(+)T淋巴细胞不是监测allo-HSCT后巨细胞病毒再感染的好生物标志物
Vânia Abadia Soares Lino,Silvana Maria Eloi Santos,Henrique Neves da Silva Bittencourt et al.
Vânia Abadia Soares Lino et al.
Background: Infection/reactivation of cytomegalovirus is a major cause of morbidity and mortality in immunocompromised transplant patients. It has already been observed in kidney and liver transplantation patients that cy...
Confidential donation confirmation as an alternative to confidential unit exclusion: 15 months experience of the HEMOMINAS foundation [0.03%]
保密捐赠确认作为排除保密单位的替代方法：HEMOMINAS基金会15个月的经验
Flávia Cristine Martineli Loureiro,Cláudia Di Lorenzo Oliveira,Anna Bárbara F Carneiro Proietti et al.
Flávia Cristine Martineli Loureiro et al.
Background: Confidential unit exclusion remains a controversial strategy to reduce the residual risk of transfusion-transmitted infections. Objective: ...